BTech in Bioengineering vs BTech in Biosciences and Bioengineering: While the academic pathways may differ slightly, both fields contribute to solving major challenges in healthcare, sustainability ...
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
People often compare the genome to a computer's program, with the cell using its genetic code to process environmental inputs and produce appropriate responses. Subscribe to our newsletter for the ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
The DNA foundation model Evo 2, first released in February 2025 as a preprint, is now published in the journal Nature. Trained on the DNA of over 100,000 species across the entire tree of life, Evo 2 ...
Researchers from New England Biolabs and Yale University have created a system for engineering the first fully synthetic bacteriophages that could help with future clinical development of phage ...
Somewhere in Michigan, 10,000 silkworms are spinning the future of supermaterials. They labor in the thick air of a warm, humid warehouse, pulling a sticky white strand from a gland in their face and ...
“Why should only the tall have access to tall genes? And why should only the smart have access to smart genes?… our goal is to give as many people as possible the opportunity to choose their genes for ...
KIT researchers succeeded for the first time in reducing the number of chromosomes in a plant using the CRISPR/Cas method – surprisingly without affecting its growth The CRISPR/Cas molecular scissors ...
An international team of researchers has used genetic engineering to create the first ever “product-ready” antivenom for snakes such as cobras and mambas. The groundbreaking research is published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results